Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Novartis and Google to fund ‘robotic pill’ maker

Firms sign up to Rani Therapeutics’ new drug delivery system

- PMLiVE

Sanofi pays $245m for FDA priority review voucher

PRV reduces review time from ten to six months

Lilly backs Bluetooth insulin device and app firm

Invests in San Diego-based medical device company Companion Medical

- PMLiVE

FDA approves two new IBS medicines

US regulator gives the nod to Actavis’ and Salix’ bowel drugs

UK Life Sciences Strategy - one year on

Express Scripts pushes for pay-for-performance in cancer

States it is the only way to fund the growing cost of cancer care

- PMLiVE

Huntingdon Life Sciences appoints Joseph Bedford

He will serve as the firm's corporate VP forglobal strategic marketing

Sanofi reception

Sanofi licenses cardiovascular therapy in South Korea

Phase III drug comes from Swedish company NeuroVive

Boehringer Ingelheim headquarters

Boehringer bags FDA approval for Spiriva-based combo

Stiolto given the thumbs up as a once-daily maintenance therapy for COPD

- PMLiVE

Amgen’s immuno-oncology drug scores in skin cancer

Firm hoping its novel treatment will be on the market be the end of this year

Sanofi appoints Suresh Kumar as EVP of external affairs

He previously worked for the Clinton Foundation focused on Sub-Saharan Africa

Nabriva Therapeutics names Elyse Seltzer as CMO

She joins from GlaxoSmithKline

EU flag

Three cancer immunotherapies amongst new CHMP approvals

BMS’ Evotaz also amongst eight new medicine recommendations

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links